Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences

WARREN, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company developing medicines to meaningfully improve patients’ lives through innovative science and delivery technologies, today announced that its management team will participate in two upcoming investor conferences in September 2024 as follows:

• HC Wainwright 26^and Annual Global Investor Conference: Presentation at 8:30 a.m. ET on Monday, September 9^and and available to organize meetings with investors
• Lake Street BIG8 Conference: Available for Investor Meetings on Thursday, September 12^and

A webcast of the presentation at HC Wainwright 26^and The annual Global Investment Conference is available on the “Events and Presentations” page of the Investors section of the company’s website. A webcast replay of that presentation will be available 30 days following the event. For more information, visit investors.aquestive.com.